About Stilla Technologies
Stilla Technologies is a company based in Villejuif (France) founded in 2013 by Clement Gay and Remi Dangla was acquired by Bio Rad in February 2025.. Stilla Technologies has raised $53.11 million across 6 funding rounds from investors including Eurazeo, Bio Rad and European Investment Bank. Stilla Technologies offers products and services including Nio® dPCR, Digital PCR Kits and Assays, and Custom Assay Design Service. Stilla Technologies operates in a competitive market with competitors including GenMark Diagnostics, Silicon Biosystems, Sense Biodetection, Mesa Biotech and Quantalife, among others.
- Headquarter Villejuif, France
- Founders Clement Gay, Remi Dangla
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stilla Technologies
Stilla Technologies offers a comprehensive portfolio of products and services, including Nio® dPCR, Digital PCR Kits and Assays, and Custom Assay Design Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Instrument for high-capacity DNA quantification and mutation detection
Kits for targeted mutation detection in various samples
In silico design and testing for personalized assays
Funding Insights of Stilla Technologies
Stilla Technologies has successfully raised a total of $53.11M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $12.73 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $12.7M
-
First Round
First Round
(29 Nov 2016)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Debt – Conventional - Stilla Technologies | Valuation |
investors |
|
| Nov, 2021 | Amount | Series B - Stilla Technologies | Valuation |
investors |
|
| Feb, 2020 | Amount | Series B - Stilla Technologies | Valuation | Illumina Ventures , Kurma Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Stilla Technologies
Stilla Technologies has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Eurazeo, Bio Rad and European Investment Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health tech startups are invested in by Illumina Ventures.
|
Founded Year | Domain | Location | |
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Stilla Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Stilla Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Stilla Technologies Comparisons
Competitors of Stilla Technologies
Stilla Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenMark Diagnostics, Silicon Biosystems, Sense Biodetection, Mesa Biotech and Quantalife, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| domain | founded_year | HQ Location |
Provider of point of care molecular diagnostics solutions
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular diagnostic kits are developed and supplied.
|
|
| domain | founded_year | HQ Location |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Stilla Technologies
Frequently Asked Questions about Stilla Technologies
When was Stilla Technologies founded?
Stilla Technologies was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Where is Stilla Technologies located?
Stilla Technologies is headquartered in Villejuif, France.
Who is the current CEO of Stilla Technologies?
Remi Dangla is the current CEO of Stilla Technologies. They have also founded this company.
Is Stilla Technologies a funded company?
Stilla Technologies is a funded company, having raised a total of $53.11M across 6 funding rounds to date. The company's 1st funding round was a Series B of $22.1M, raised on Nov 29, 2016.
What does Stilla Technologies do?
Stilla Technologies was founded in 2013 in Villejuif, France, within the biotechnology sector. Digital PCR systems for research applications are provided, operating on Crystal Digital PCR principles in a compact format with single consumables. Data analysis is supported by Crystal Miner software, which identifies positive and negative droplets across three fluorescence channels. Operations focus on reliable tools for scientific workflows.
Who are the top competitors of Stilla Technologies?
Stilla Technologies's top competitors include GenMark Diagnostics, Silicon Biosystems and ReadyGo.
What products or services does Stilla Technologies offer?
Stilla Technologies offers Nio® dPCR, Digital PCR Kits and Assays, and Custom Assay Design Service.
Who are Stilla Technologies's investors?
Stilla Technologies has 13 investors. Key investors include Eurazeo, Bio Rad, European Investment Bank, Idinvest Partners, and Kurma Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.